Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.

Your data on MRCVSonline

Your privacy

The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

Google Analytics (Performance)

MRCVSonline uses Google Analytics to track which articles/features are most popular, so we can focus on these areas to improve the user experience.

Google analytics places four cookies on your browser (_utma, _utmb, _utmc, _utmz).

Google's cookie policy can be found here.

If you allow Google Analytics MRCVSonline will place a cookie named 'allowAnalytics'.
The 'allowAnalytics' cookie only contains the value 'YES' and will expire every 365 days.
The cookie will be forced to expire if you disable Google Analytics.
Allow Google Analytics Off

MRCVS user - (Strictly necessary)

The 'MRCVSuser' cookie is used to determine if you have logged into the website.

Logging into the website allows certain privileged features, for example, single click recording of CPD time. This cookie is destroyed each time you close your browser.

Preferences - (Strictly necessary)

The 'savedDataPreferences' cookie is set once you click 'Accept All', 'Reject Non Essential' or 'Save & Exit'.

The 'savedDataPreferences' cookie is only used to prevent you from being asked about your data preferences every time you visit a page.

The cookie will only contain the value 'YES' and will expire every 365 days.

iPad app - (Functionality)

If the website is viewed on an iPhone, iPad or iPod touch, the user will be offered the functionality of the iOS application that we have developed.

If the user would like to view the website instead, a cookie will be placed with the value='1' with a month expiry date.
This will be used to check if the user would prefer to visit the website instead.

Third Party

To support our journalism, MRCVSonline will, from time to time, link YouTube videos, as well as use social media such as Facebook or Twitter.

MRCVSonline cannot control these cookies from outside sources and we advise you to check with the relevant third party for more information..
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
Send Cancel

Study reveals new insights into canine mammary cancer
The study found that spaying can increase the risk of more aggressive cancers.

Higher serum oestrogen levels linked to improved survival times

US researchers have shed new light on the complex role of oestrogen in the development of canine mammary tumours.

The study, published in PLOS ONE, found that while spaying at a young age can reduce a dog’s risk of developing mammary cancer, it can increase the risk of more aggressive cancers.

Furthermore, the study found that in spayed animals with mammary tumours, higher serum oestrogen levels were protective, associated with longer times to metastasis and improved survival times.

Senior author and veterinary oncologist Karin U Sorenmo from the University of Pennsylvania’s School of Veterinary Medicine (Penn Vet), said: “Dogs that remain intact and have their ovaries develop many more mammary tumors than dogs that were spayed, so removing that source of estrogen does have a protective effect. 

“Estrogen does seem to drive mammary cancer development. But what it does for progression to metastasis—that I think is more complicated.”

In the study, researchers assessed 159 dogs with mammary cancer, 130 of which were spayed as part of the study and 29 that remain intact. Besides surgically removing the dogs’ measurable tumours, the team collected information on serum oestrogen levels, tumour types, disease grade and stage, time to metastasis, and survival time. 

They found that, despite oestrogen’s link with an increased risk of developing mammary tumours, higher serum oestrogen levels appeared to help dogs avoid some of the riskiest aspects of their disease.

Interestingly, when dogs were spayed at the same time as having their tumours removed, those with oestrogen-receptor positive tumours that had higher serum oestrogen took longer to develop metastatic disease and survived longer than dogs with lower oestrogen levels - confirming that such tumours depend on oestrogen for progression.

The researchers also found that the protective role of oestrogen was also pronounced in dogs with oestrogen-receptor negative mammary tumours. In these higher-risk cancers, high serum oestrogen was associated with delayed or absent metastasis.

Furthermore, the study showed that dogs with low oestrogen are at a far higher risk for developing other non-mammary aggressive fatal tumours after mammary tumour surgery.

Sorenmo and her colleagues have been studying mammary tumours in dogs as a way to improve care and treatment for pets, but to also reveal insights into human breast cancer. 

Their research used data from the Penn Vet Shelter Canine Mammary Tumour Program, through which shelter dogs with mammary tumours receive treatment, are studied by researchers like Sorenmo, and found foster or permanent homes.

Image (C) Penn State University.

Become a member or log in to add this story to your CPD history

VetCT app offered to students and new graduates

News Story 1
 The VetCT app is being offered for free to students and new veterinary graduates for their first three months in practice. The app provides a service for vets to send case information to a global team of Diploma-holding specialists, who can provide advice and support via instant call-back, text chat, written report, or virtual appointment.

Time on the app is automatically logged as CPD with quarterly certificates being generated for users. Additional services include the ability to book bespoke CPD, significant event reviews, and live training sessions such as surgical procedures.

The app is downloadable for both iOS and Android systems. 

Click here for more...
News Shorts
HORIBA to host CPD webinar

HORIBA has announced that it will host an online CPD meeting focusing on 'Exotic Parasites - The Importance of Testing in The Imported Dog'. Ian Wright (BVMS, MSc, MRCVS), head of ESCCAP UK and Ireland, will present on the importance of testing protocols in diseases of imported dogs.

The meeting will provide attendees with an overview of emerging veterinary diseases with a particular focus on exotic parasites, and discuss the importance of accurate testing protocols and equipment, alongside a final Q&A session.

The webinar will take place on Thursday July 1, from 19.30pm to 21.00pm BST. For free registration and more information visit the Horiba website or